Address: C76, Balewadi, Pune, Maharashtra
The global eCOA, eSource & Clinical Trials Market is projected to grow at a high CAGR. Electronic Clinical Outcome Assessment (eCOA) is a method of accumulating data electronically in clinical trials. It helps in significantly increasing the quality of study data while meeting regulatory requirements. Paper-based data collection faces various challenges for the accuracy of the data used for conducting clinical trials. As the entire clinical trial process is robust and does not allow for much flexibility, organizations are obliged to follow strict protocols and the changes are tedious to execute. This has encouraged many healthcare companies and governments to conduct clinical trials in a digital way to reduce overall cost and lengthy timelines.
Top Driver: Growing Concern of Pharmaceutical Companies on Efficiency and Stringent Regulations
Clinical trials are witnessing a disruptive change as an increased number of pharmaceutical companies focus on addressing the growing concerns about efficiency. With the emerging power of digitization through eCOA, eSource, and clinical trial solutions, companies have set their focus on enhancing R&D efficiency, streamlining clinical trials, and cutting costs of lengthy processes. Moreover, the growing demand for the timely launch of drugs, healthcare solutions, and devices, coupled with the growing stringency of regulations for product approval, the market is anticipated to grow at a significant pace.
eCOA to Make Crucial Contribution to Growth of Global eCOA, eSource and Clinical Trials Market
The global eCOA, eSource and clinical trials market can be segmented on the basis of solution type into eCOA (Electronic clinical Outcome assessment), eSource, Electronic Data Capture (EDC), Clinical Trials Solutions. The eCOA segment accounted for a larger market share owing to the increasing number of clinical trials across various domains in the medical science. On the basis of deployment the market can be segmented into Licensed Enterprise (On Premise), Cloud-based (SaaS). On the basis of end use the market is segmented into Contract Research Organizations Hospitals & Other Healthcare Facilities, Pharmaceutical/Biotechnology/Medical Devices Companies, Educational & Research Institutes.
Rising Investments in Technologies to Benefit North America Market
North American countries such as the US are predicted to maximize their spending on the investment in gathering the clinical trials which can be used for having better flexibility in availing the data whenever and wherever required. This is anticipated to help the industry flourish in the coming years. Furthermore, there is a steep increase in the research and development which requires the data related to the clinical trials to be stored, and hence is the need of the hour, which would help the industry propel in the coming years.
Players to Focus on eCOA, eSource & Clinical Trials Market
The global cognitive computing market is expected to stay fragmented with the increase in the number of new entrants in the coming years. OpenClinica, LLC, CRF Health, Inc., ArisGlobal LLC, ICON plc, PAREXEL International Corporation, OmniComm Systems, Inc., Oracle Corp, PAREXEL International Corporation, Medpace Holdings, Inc. among others could be at the forefront of the competition in the global cognitive computing market.
Athenahealth: In May 2018, EHR provider athenahealth reviewed $6.9Bn acquisition offer. The company did partnership to support clinical trials recruitment has received an unsolicited acquisition offer from Elliot Management, skyrocketing the EHR provider’s stock.
Genstar Capital: In July 2018, Genstar Capital, a leading investor in healthcare technology and services companies, is pleased to announce the acquisition of CRF Health, a global provider of eCOA and eConsent solutions for the life sciences industry. As part of the transaction, CRF will be combined with Bracket, a provider of software and technology-enabled solutions utilized in clinical trials. Bracket is a portfolio company of Genstar.
Scope of the Report
By Solution Type
By Deployment
By End-User
By Region
Key Reasons to Purchase this Report
Table of Content
Chapter 2 Our Research Practice
Chapter 4 Covid-19 Impact Analysis
4.3 Key Factor Impact Analysis
Chapter 5 Global ECOA, eSource and Clinical Trials Market Forces
5.2 Porter’s Five Forces Analysis
5.2.2 Threats From New Entrants
5.2.4 Threat From Substitute Product
Chapter 6 Global ECOA, eSource and Clinical Trials Market -Industry Snapshots
6.1.1 Global ECOA, eSource and Clinical Trials Market Value, 2019 – 2028, (US$ Bn)
6.2.2 Restraint/Challenges analysis
6.3 Supply Chain/Value Chain Analysis
Chapter 7 Global ECOA, eSource and Clinical Trials Market Analysis, by Solution Type
7.2 Key Findings for ECOA, eSource and Clinical Trials Market- By Solution Type
7.2.1 ECOA, eSource and Clinical Trials Market- eCOA (Electronic clinical Outcome assessment)
7.2.2 ECOA, eSource and Clinical Trials Market- eSource
7.2.3 ECOA, eSource and Clinical Trials Market- Electronic Data Capture (EDC)
7.2.4 ECOA, eSource and Clinical Trials Market- Clinical Trials Solutions
Chapter 8 Global ECOA, eSource and Clinical Trials Market Analysis, by Deployment
8.2 Key Findings for ECOA, eSource and Clinical Trials Market- By Deployment
8.2.1 ECOA, eSource and Clinical Trials Market- Licensed Enterprise (On Premise)
8.2.2 ECOA, eSource and Clinical Trials Market- Cloud-based (SaaS)
Chapter 9 Global ECOA, eSource and Clinical Trials Market Analysis, by End User
9.2 Key Findings for ECOA, eSource and Clinical Trials Market- By End User
9.2.1 ECOA, eSource and Clinical Trials Market- Contract Research Organizations
9.2.2 ECOA, eSource and Clinical Trials Market- Hospitals & Other Healthcare Facilities
9.2.4 ECOA, eSource and Clinical Trials Market- Educational & Research Institutes
Chapter 10 ECOA, eSource and Clinical Trials Market Analysis by Region
10.1 Key Findings for ECOA, eSource and Clinical Trials Market- By region
10.2.1 Global ECOA, eSource and Clinical Trials Market Analysis, By Solution Type, 2019 – 2028
10.2.2 Global ECOA, eSource and Clinical Trials Market Analysis, By Deployment, 2019 – 2028
10.2.3 Global ECOA, eSource and Clinical Trials Market Analysis, By End User, 2019 – 2028
10.3 ECOA, eSource and Clinical Trials Market – North America
10.3.5 North America Market, By Solution Type
10.3.6 North America Market, By Deployment
10.3.7 North America Market, By End User
10.4 ECOA, eSource and Clinical Trials Market – Europe
10.4.7 Europe Market, By Solution Type
10.4.8 Europe Market, By Deployment
10.4.9 Europe market by, End User
10.5 ECOA, eSource and Clinical Trials Market – Asia Pacific
10.5.6 Asia Pacific Market, By Solution Type
10.5.7 Asia Pacific Market, By Deployment
10.5.8 Asia Pacific Market, By End User
10.6 ECOA, eSource and Clinical Trials Market – SAMEA
10.6.2 Middle East & Africa (MEA)
10.6.5 South America, Middle East and Africa Market, By Solution Type
10.6.6 South America, Middle East and Africa Market, By Deployment
10.6.7 South America, Middle East and Africa Market, By End User
Chapter 11 Market Competition Analysis
11.1 Market Share/Positioning Analysis
11.1.1 Market Positioning of Key Vendors, 2019
11.1.2 Key Strategies Adopted by the Leading Players
Chapter 12 Company Profiles- Snapshot
12.5 PAREXEL International Corporation
12.8 PAREXEL International Corporation
*More than 10 Companies are profiled in this Research Report*
*Financials would be provided on a best efforts basis for private companies”
Please fill out the form to receive sample pages of the report